A Randomized, Double-Blinded, Phase II Study of Maintenance Pembrolizumab versus Placebo after First-line Chemotherapy in Patients with Metastatic Urothelial Cancer

Type of Cancer
Genito-Urinary

Phase

Division (Location)

Study ID

NCT#

Brief Description
A Randomized, Double-Blinded, Phase II Study of Maintenance Pembrolizumab versus Placebo after First-line Chemotherapy in Patients with Metastatic Urothelial Cancer

To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.